Related Experiment Video
Updated: Aug 10, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Plasma extracellular microRNAs are related to AIDS/cerebral toxoplasmosis co-infection
Ingrid de Siqueira Pereira1, Marta Marques Maia1, Allecineia Bispo da Cruz1
1Laboratório de Biologia Molecular de Parasitas e Fungos, Instituto Adolfo Lutz, Sao Paulo, Brazil.
Abstract:
This study investigated the potential of five miRNA candidates for cerebral toxoplasmosis/HIV co-infection (CT/HIV) biomarkers. miR-155-5p, miR-146a-5p, miR-21-5p, miR-125b-5p and miR-29c-3p were tested in 79 plasma divided into groups: 32 CT/HIV patients; 27 individuals with asymptomatic toxoplasmosis (AT); and 20 individuals seronegative for toxoplasmosis (NC). From each was collected peripheral blood/EDTA for laboratory diagnosis. Blood cells for DNA extractions (molecular diagnosis), plasma for RNA extractions (gene expression) and ELISA (serological diagnosis). miRNA expression was performed by qPCR, and values were expressed in Relative Quantification (RQ). Among the five miRNAs, miR-21-5p and miR-146a-5p were up-expressed in CT/HIV group when compared with AT and NC groups. RQ means for miR-21-5p and miR-146a-5p in CT/HIV group were 3.829 and 2.500, while in AT group, were 1.815 and 1.661, respectively. Differences between 3 groups were statistically significant (Kruskal-Wallis ANOVA test), as well as CT/HIV and AT groups (Mann-Whitney test). Plasma of CT/HIV and AT groups expressed similar levels of miR-29c-3p, miR-155-5p and miR-125b-5p. As NC group was different of CT/HIV and AT groups, differences between three groups were statistically significant (Kruskal-Wallis ANOVA test). No difference was shown between CT/HIV and AT groups (Mann-Whitney test). These results suggest the host miRNAs modulation by Toxoplasma gondii.
Insights
Biomarkers for cerebral toxoplasmosis/HIV co-infection (CT/HIV) were identified using microRNAs (miRNAs). miR-21-5p and miR-146a-5p showed significant upregulation in CT/HIV patients, suggesting their potential as diagnostic markers.
Area of Science:
- * Infectious Diseases
- * Molecular Biology
- * Immunology
Background:
- * Cerebral toxoplasmosis is a significant opportunistic infection in individuals with HIV/AIDS.
- * Accurate and early diagnosis of cerebral toxoplasmosis/HIV co-infection (CT/HIV) is crucial for effective treatment and patient outcomes.
- * MicroRNAs (miRNAs) are emerging as potential biomarkers for various diseases due to their role in gene regulation.
Purpose of the Study:
- * To investigate the potential of five specific miRNA candidates (miR-155-5p, miR-146a-5p, miR-21-5p, miR-125b-5p, and miR-29c-3p) as biomarkers for CT/HIV.
- * To compare miRNA expression profiles in patients with CT/HIV, asymptomatic toxoplasmosis (AT), and healthy controls (NC).
Main Methods:
- * Plasma samples were collected from 79 participants categorized into CT/HIV (n=32), AT (n=27), and NC (n=20) groups.
- * miRNA expression levels were quantified using quantitative polymerase chain reaction (qPCR) and expressed as Relative Quantification (RQ).
- * Statistical analyses included Kruskal-Wallis ANOVA and Mann-Whitney tests to determine significant differences between groups.
Main Results:
- * miR-21-5p and miR-146a-5p were significantly upregulated in the CT/HIV group compared to both AT and NC groups (RQ values: CT/HIV vs. AT for miR-21-5p = 3.829 vs. 1.815; for miR-146a-5p = 2.500 vs. 1.661).
- * miR-29c-3p, miR-155-5p, and miR-125b-5p showed similar expression levels between CT/HIV and AT groups, but differed from the NC group.
- * Statistical analysis confirmed significant differences in miRNA expression between the three study groups.
Conclusions:
- * The study identified miR-21-5p and miR-146a-5p as promising candidate biomarkers for the diagnosis of cerebral toxoplasmosis in HIV-infected individuals.
- * The observed miRNA modulation suggests a role for host miRNAs in the pathogenesis of Toxoplasma gondii infection.
- * Further research is warranted to validate these findings and explore their clinical utility in CT/HIV management.
Related Concept Videos
Fungal Phylum Microsporidia
Cytomegalovirus Disease
Cryptococcal Meningitis
Malaria
Toxoplasmosis
Amebiasis

